ArticleProceedings of the National Academy of Sciences of the United States of America2009

Efalizumab binding to the LFA-1 alphaL I domain blocks ICAM-1 binding via steric hindrance.

Sheng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.